Logo image of HEP

Holly Energy Partners LP (HEP) Stock Fundamental Analysis

USA - NYSE:HEP - US4357631070

20.45 USD
-0.16 (-0.78%)
Last: 11/30/2023, 8:04:00 PM
20.55 USD
+0.1 (+0.49%)
After Hours: 11/30/2023, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, HEP scores 4 out of 10 in our fundamental rating. HEP was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. There are concerns on the financial health of HEP while its profitability can be described as average. HEP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

HEP had positive earnings in the past year.
In the past year HEP had a positive cash flow from operations.
HEP had positive earnings in each of the past 5 years.
HEP had a positive operating cash flow in each of the past 5 years.
HEP Yearly Net Income VS EBIT VS OCF VS FCFHEP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

1.2 Ratios

HEP has a Return On Assets (8.82%) which is comparable to the rest of the industry.
With a decent Return On Equity value of 26.66%, HEP is doing good in the industry, outperforming 65.90% of the companies in the same industry.
HEP's Return On Invested Capital of 7.61% is on the low side compared to the rest of the industry. HEP is outperformed by 60.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HEP is significantly below the industry average of 21.66%.
Industry RankSector Rank
ROA 8.82%
ROE 26.66%
ROIC 7.61%
ROA(3y)8.55%
ROA(5y)8.88%
ROE(3y)39.57%
ROE(5y)43.91%
ROIC(3y)7.99%
ROIC(5y)8.68%
HEP Yearly ROA, ROE, ROICHEP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 10 20 30 40 50

1.3 Margins

HEP has a better Profit Margin (40.91%) than 80.18% of its industry peers.
HEP's Profit Margin has improved in the last couple of years.
HEP has a Operating Margin of 42.93%. This is in the better half of the industry: HEP outperforms 74.65% of its industry peers.
In the last couple of years the Operating Margin of HEP has declined.
Looking at the Gross Margin, with a value of 62.77%, HEP is in the better half of the industry, outperforming 61.75% of the companies in the same industry.
In the last couple of years the Gross Margin of HEP has declined.
Industry RankSector Rank
OM 42.93%
PM (TTM) 40.91%
GM 62.77%
OM growth 3Y-6.27%
OM growth 5Y-3.66%
PM growth 3Y-2.17%
PM growth 5Y2.34%
GM growth 3Y-4.02%
GM growth 5Y-2.47%
HEP Yearly Profit, Operating, Gross MarginsHEP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HEP is still creating some value.
Compared to 1 year ago, HEP has more shares outstanding
The debt/assets ratio for HEP has been reduced compared to a year ago.
HEP Yearly Shares OutstandingHEP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
HEP Yearly Total Debt VS Total AssetsHEP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B 2.5B

2.2 Solvency

HEP has a debt to FCF ratio of 4.77. This is a neutral value as HEP would need 4.77 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.77, HEP is in line with its industry, outperforming 55.30% of the companies in the same industry.
HEP has a Debt/Equity ratio of 1.71. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of HEP (1.71) is worse than 81.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.71
Debt/FCF 4.77
Altman-Z N/A
ROIC/WACC1.05
WACC7.28%
HEP Yearly LT Debt VS Equity VS FCFHEP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

2.3 Liquidity

HEP has a Current Ratio of 1.15. This is a normal value and indicates that HEP is financially healthy and should not expect problems in meeting its short term obligations.
HEP's Current ratio of 1.15 is in line compared to the rest of the industry. HEP outperforms 48.39% of its industry peers.
A Quick Ratio of 1.15 indicates that HEP should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.15, HEP is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
HEP Yearly Current Assets VS Current LiabilitesHEP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.86% over the past year.
Measured over the past years, HEP shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.41% on average per year.
Looking at the last year, HEP shows a quite strong growth in Revenue. The Revenue has grown by 11.56% in the last year.
HEP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.80% yearly.
EPS 1Y (TTM)13.86%
EPS 3Y-0.56%
EPS 5Y-1.41%
EPS Q2Q%51.52%
Revenue 1Y (TTM)11.56%
Revenue growth 3Y0.91%
Revenue growth 5Y3.8%
Sales Q2Q%6.31%

3.2 Future

Based on estimates for the next years, HEP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.09% on average per year.
HEP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.53% yearly.
EPS Next Y7.71%
EPS Next 2Y11.49%
EPS Next 3Y9.09%
EPS Next 5YN/A
Revenue Next Year9.05%
Revenue Next 2Y7.91%
Revenue Next 3Y5.53%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HEP Yearly Revenue VS EstimatesHEP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
HEP Yearly EPS VS EstimatesHEP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.82, the valuation of HEP can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of HEP is on the same level as its industry peers.
HEP's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 9.29, which indicates a very decent valuation of HEP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HEP is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of HEP to the average of the S&P500 Index (22.88), we can say HEP is valued rather cheaply.
Industry RankSector Rank
PE 10.82
Fwd PE 9.29
HEP Price Earnings VS Forward Price EarningsHEP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

HEP's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HEP is more expensive than 70.51% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HEP indicates a somewhat cheap valuation: HEP is cheaper than 68.66% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.05
EV/EBITDA 11.73
HEP Per share dataHEP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.4
PEG (5Y)N/A
EPS Next 2Y11.49%
EPS Next 3Y9.09%

5

5. Dividend

5.1 Amount

HEP has a Yearly Dividend Yield of 6.85%, which is a nice return.
HEP's Dividend Yield is a higher than the industry average which is at 6.17.
Compared to an average S&P500 Dividend Yield of 2.38, HEP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.85%

5.2 History

The dividend of HEP decreases each year by -12.46%.
HEP has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of HEP decreased recently.
Dividend Growth(5Y)-12.46%
Div Incr Years1
Div Non Decr Years1
HEP Yearly Dividends per shareHEP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2 2.5

5.3 Sustainability

HEP pays out 74.17% of its income as dividend. This is not a sustainable payout ratio.
DP74.17%
EPS Next 2Y11.49%
EPS Next 3Y9.09%
HEP Yearly Income VS Free CF VS DividendHEP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M
HEP Dividend Payout.HEP Dividend Payout, showing the Payout Ratio.HEP Dividend Payout.PayoutRetained Earnings

Holly Energy Partners LP

NYSE:HEP (11/30/2023, 8:04:00 PM)

After market: 20.55 +0.1 (+0.49%)

20.45

-0.16 (-0.78%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-02 2023-11-02/bmo
Earnings (Next)02-22 2024-02-22/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners1.48%
Ins Owner Change0%
Market Cap2.59B
Analysts46
Price Target21.93 (7.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.85%
Yearly Dividend1.47
Dividend Growth(5Y)-12.46%
DP74.17%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.42%
Min EPS beat(2)-10.9%
Max EPS beat(2)-3.94%
EPS beat(4)2
Avg EPS beat(4)-1.66%
Min EPS beat(4)-10.9%
Max EPS beat(4)4.89%
EPS beat(8)3
Avg EPS beat(8)-5.14%
EPS beat(12)7
Avg EPS beat(12)1.36%
EPS beat(16)10
Avg EPS beat(16)10.6%
Revenue beat(2)1
Avg Revenue beat(2)-2.31%
Min Revenue beat(2)-5.17%
Max Revenue beat(2)0.55%
Revenue beat(4)2
Avg Revenue beat(4)1.39%
Min Revenue beat(4)-5.34%
Max Revenue beat(4)15.53%
Revenue beat(8)5
Avg Revenue beat(8)2.44%
Revenue beat(12)7
Avg Revenue beat(12)1.28%
Revenue beat(16)9
Avg Revenue beat(16)1.05%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.03%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE 10.82
Fwd PE 9.29
P/S 4.43
P/FCF 8.05
P/OCF 7.37
P/B 2.89
P/tB 5.16
EV/EBITDA 11.73
EPS(TTM)1.89
EY9.24%
EPS(NY)2.2
Fwd EY10.76%
FCF(TTM)2.54
FCFY12.42%
OCF(TTM)2.78
OCFY13.57%
SpS4.62
BVpS7.09
TBVpS3.97
PEG (NY)1.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.82%
ROE 26.66%
ROCE 9.64%
ROIC 7.61%
ROICexc 7.65%
ROICexgc 9.02%
OM 42.93%
PM (TTM) 40.91%
GM 62.77%
FCFM 55%
ROA(3y)8.55%
ROA(5y)8.88%
ROE(3y)39.57%
ROE(5y)43.91%
ROIC(3y)7.99%
ROIC(5y)8.68%
ROICexc(3y)8.05%
ROICexc(5y)8.73%
ROICexgc(3y)9.47%
ROICexgc(5y)10.46%
ROCE(3y)10.11%
ROCE(5y)10.99%
ROICexcg growth 3Y-13.07%
ROICexcg growth 5Y-5.5%
ROICexc growth 3Y-12.24%
ROICexc growth 5Y-4.64%
OM growth 3Y-6.27%
OM growth 5Y-3.66%
PM growth 3Y-2.17%
PM growth 5Y2.34%
GM growth 3Y-4.02%
GM growth 5Y-2.47%
F-Score8
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 1.71
Debt/FCF 4.77
Debt/EBITDA 4.36
Cap/Depr 29.92%
Cap/Sales 5.1%
Interest Coverage 2.49
Cash Conversion 100.2%
Profit Quality 134.45%
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z N/A
F-Score8
WACC7.28%
ROIC/WACC1.05
Cap/Depr(3y)64.95%
Cap/Depr(5y)54.8%
Cap/Sales(3y)12.41%
Cap/Sales(5y)10.45%
Profit Quality(3y)126.74%
Profit Quality(5y)127.52%
High Growth Momentum
Growth
EPS 1Y (TTM)13.86%
EPS 3Y-0.56%
EPS 5Y-1.41%
EPS Q2Q%51.52%
EPS Next Y7.71%
EPS Next 2Y11.49%
EPS Next 3Y9.09%
EPS Next 5YN/A
Revenue 1Y (TTM)11.56%
Revenue growth 3Y0.91%
Revenue growth 5Y3.8%
Sales Q2Q%6.31%
Revenue Next Year9.05%
Revenue Next 2Y7.91%
Revenue Next 3Y5.53%
Revenue Next 5YN/A
EBIT growth 1Y18.14%
EBIT growth 3Y-5.42%
EBIT growth 5Y0%
EBIT Next Year83.08%
EBIT Next 3Y24.67%
EBIT Next 5YN/A
FCF growth 1Y38.39%
FCF growth 3Y3.03%
FCF growth 5Y8.56%
OCF growth 1Y5.91%
OCF growth 3Y3.67%
OCF growth 5Y6.77%